Skip to main content

Curevac N.V.(CVAC-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Curevac N.V.

Friedrich-Miescher-Strasse 15
Tubingen 2M 72076 DEU
P: 49-70-71988-30
F: 719-883-1101
http://www.curevac.com

Profile

CureVac B.V. is a clinical-stage biopharmaceutical company. It engages in developing medicines based on messenger ribonucleic acid. The company's lead clinical programs include CV8102. CureVac B.V. is based in Germany.

Key Executives

NameTitle
Pierre KemulaCFO
Igor SplawskiChief Scientific Officer
Malte GreuneCOO
Alexander ZehnderCEO
Myriam MendilaOther Executive Officer